Summer program at UCLA helps build more diverse pipeline for health care field
For many college students, the summer break means basking at the beach, traveling to exotic locales or just hanging out with friends. But this summer meant something quite different to a dedicated group of college students from disadvantaged backgrounds. Thanks to a free program offered by the David Geffen School of Medicine at UCLA, these students took part in a six-week summer program to further their dreams of becoming health care professionals.“I was ecstatic about this opportunity and couldn’t wait to get involved,” said Nahun Flores, a 29-year-old who attends Chaffey College in Rancho Cucamonga, about 60 miles east of UCLA. Flores was one of 80 participants from underrepresented minorities and underprivileged backgrounds who have an interest in medicine, dentistry, nursing and other health professions who took advantage of theSummer Health Professions Education Program, known as SHPEP, for college sophomores, juniors and community college students.A native of Nicaragua, Flores said he is grateful for the opportunity to participate in the program, which was administered at the Geffen School of Medicine and 12 other U.S. sites, thanks to a generousgrant from the Robert Wood Johnson Foundation.“When we migrated to the U.S.,” Flores said, “we had access to health care; however we encountered many challenges because of health disparities. Facing those challenges and going through those experiences has impacted my character and made me real...
Abstract Laryngeal trauma from prolonged endotracheal intubation occurs in patients of all ages. Most changes are superficial and heal quickly. Injuries that are found consistently during intubation include nonspecific changes, edema, granulation tissue, ulceration, and othermiscellaneous injuries. In thispapersignificant, severe, and lasting trauma of the larynx has been classified on thebasis of theknown factors in pathogenesis, observations made atendoscopy, and photographic documentation. This classification has required introduction of new descriptive terminology: "tongues of granulation tissue," &q...
PMID: 30012011 [PubMed - in process]
PMID: 30012010 [PubMed - in process]
PMID: 30012009 [PubMed - in process]
The FDA has approved the first protease inhibitor-based single-tablet regimen for the treatment of HIV-1 infection in treatment-naive and certain virologically suppressed adult patients.FDA Approvals
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Henk-Jan Westeneng, Ammar Al-Chalabi, Orla Hardiman, Thomas PA Debray, Leonard H van den Berg
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Susana Carmona, Kathleen Zahs, Elizabeth Wu, Kelly Dakin, Jose Bras, Rita GuerreiroSummaryAlzheimer's disease is a genetically complex disorder; rare variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been shown to as much as triple an individual's risk of developing Alzheimer's disease. TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather th...
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Farhat Husain, Jerry Vanatta
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s):
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Lee H Schwamm